|
|
|
FDA-Approved First Treatment for Idiopathic Hypersomnia
September 16, 2021
 |
The US Food and Drug Administration (FDA) has just approved the first treatment for adult idiopathic hypersomnia, a condition in which patients experience chronic excessive daytime sleepiness, sleep inertia, prolonged yet non-restorative nighttime sleep and naps, and cognitive impairment... |
|
Continue reading
|
|
|
|
Short Sleep Tied to Increased Dementia Risk
May 4, 2021
 |
In a recent study, the association between sleep dysregulation and dementia was examined. Data from 7,959 participants of the Whitehall II study was analyzed for sleep duration and the incidence of dementia, using a 25-year follow-up. A total of... |
|
Continue reading (Members only)
|
|
|
|
Histamine 3 Receptor Inverse Agonist For Cognitive Disorders
February 26, 2021
 |
istamine H3 receptors, found throughout the cortex and hippocampus, have been hypothesized to be involved with cognition, learning, and memory. Several preclinical animal model studies have shown that H3 receptor antagonists/inverse agonists may have procognitive effects; however... |
|
Continue reading (Members only)
|
|